Stay updated on Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor backend update with no changes to the displayed study information.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision has been updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, a software revision with no impact on study data, content, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedFooter shows Revision: v3.3.4 after removing v3.3.3, a minor metadata update that does not affect study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded a dedicated Locations section listing California and Massachusetts sites for the study. The page now includes a revision note (Revision: v3.3.3) and the separate 'California Locations' and 'Massachusetts Locations' entries were removed.SummaryDifference0.3%

- Check108 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. This is a minor page metadata update and does not affect study details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.